1. Home
  2. EE vs IVA Comparison

EE vs IVA Comparison

Compare EE & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

HOLD

Current Price

$35.79

Market Cap

1.2B

Sector

Utilities

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.40

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EE
IVA
Founded
2003
2011
Country
United States
France
Employees
1046
77
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
EE
IVA
Price
$35.79
$5.40
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$39.20
$16.20
AVG Volume (30 Days)
362.3K
254.3K
Earning Date
05-06-2026
03-30-2026
Dividend Yield
0.96%
N/A
EPS Growth
0.79
N/A
EPS
0.37
N/A
Revenue
$1,228,263,000.00
N/A
Revenue This Year
$23.59
N/A
Revenue Next Year
$24.37
$751.20
P/E Ratio
$97.89
N/A
Revenue Growth
44.26
N/A
52 Week Low
$21.29
$2.94
52 Week High
$43.18
$7.98

Technical Indicators

Market Signals
Indicator
EE
IVA
Relative Strength Index (RSI) 55.89 48.36
Support Level $35.10 $4.98
Resistance Level $43.18 $6.42
Average True Range (ATR) 1.44 0.24
MACD 0.26 0.05
Stochastic Oscillator 80.54 44.54

Price Performance

Historical Comparison
EE
IVA

About EE Excelerate Energy Inc.

Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: